CoChat

CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer’s disease

Open access
Haense, C., Buerger, K., Kalbe, E., Drzezga, A., Teipel, S. J., Markiewicz, P., Herholz, K., Heiss, W. D., Hampel, H. · 2008 · European Journal of Neurology
Cited by 55

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Background and purpose: We investigated associations between severity of cognitive impairment, cerebrospinal fluid (CSF) concentrations of total‐tau (t‐tau) protein and tau phosphorylated at threonin 181 (p‐tau 181) and regional glucose metabolism measured with 18F‐fluorodeoxyglucose‐positron emission tomography (18F‐FDG‐PET) in patients with probable Alzheimer’s disease (AD). Methods: In 38 patients (mean age 66.5 ± 8.0 years) with AD, Mini‐Mental State Examination (MMSE) scores were evaluated and CSF levels of t‐tau and p‐tau 181 measured. All patients underwent an 18F‐FDG‐PET scan. Image analysis including correlation analysis and principal component analysis (PCA) were performed using SPM5 and VINCI. Results: Dementia severity (MMSE 21.2 ± 4.9) correlated well with metabolic impairment especially in left hemisphere association areas that are typically affected in patients with AD (e.g. inferior parietal lobule, r = 0.512; medial temporal gyrus, r = 0.478; inferior temporal gyrus, r = 0.488; precuneus, r = 0.468; PCA: r = 0.639, F = 7.751; all P < 0.001). There were no associations between t‐tau and p‐tau 181 with dementia severity and only weak correlations between t‐tau and cerebral glucose metabolism (superior parietal gyrus, r = −0.325, P < 0.05; precentral gyrus r = −0.418, P < 0.01; amygdala r = −0.362, P < 0.05). No correlations were found between p‐tau 181 and regional hypometabolism in FDG‐PET. Conclusion: MMSE and CSF t‐tau represent different aspects of disease severity. Whilst MMSE is closely related to impaired cerebral glucose metabolism, CSF t‐tau is less closely related and appears to be less well suited for assessment of disease progression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1468-1331.2008.02274.x

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 55

Metadata

Authors
Haense, C., Buerger, K., Kalbe, E., Drzezga, A., Teipel, S. J., Markiewicz, P., Herholz, K., Heiss, W. D., & Hampel, H.
Venue
European Journal of Neurology
Publisher
Wiley
Published
2008-10-06
Volume
15
Issue
11
Pages
1155-1162
ISSN
  • 1351-5101 (ISSN-L)
  • 1468-1331
OpenAlex
W2013267861
Cited by
55
References
9
FWCI
4.39
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer’s disease. https://app.cochat.ai/papers/10.1111/j.1468-1331.2008.02274.x
The paper
Haense, C., Buerger, K., Kalbe, E., Drzezga, A., Teipel, S. J., Markiewicz, P., Herholz, K., Heiss, W. D., & Hampel, H. (2008). CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer’s disease. European Journal of Neurology. https://doi.org/10.1111/j.1468-1331.2008.02274.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.